Sector Chart Charles River Laboratories International, Inc. CBOE
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
CBOE
23:59:50 21/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 295.33 USD | +1.32% |
|
+5.47% | +47.92% |
| 08-21 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| 08-20 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 51.61B | |||||
| 44.89B | - | - | - | - | - |
| 42.77B | |||||
| 42.58B | |||||
| 31.82B |
Select your edition
All financial news and data tailored to specific country editions
